Pay in 4 interest-free payments of $6.80 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Future generations of incretin agonists may be able to maintain the reduction in blood glucose and body weight while minimizing these off-target effects
*Correspondence: Lang Li, [email protected] These authors have contributed equally to this work This article was submitted to Cardiovascular and Smooth Muscle Pharmacology, a section of the journal Frontiers in Pharmacology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Epub 2006 Sep 27
The following sections elaborate on these aspects in detail for individual cancer types, and this chapter concludes with a comprehensive analysis
This is especially important for people who have difficulty absorbing nutrients through the digestive system
Tatsumi, R., Hattori, A., Ikeuchi, Y., Anderson, J
US$ 20.12
US$ 24.89
US$ 22.52
US$ 24.49
US$ 21.69
US$ 28.81
